Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pedigree Analysis

Pedigree Analysis

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Mutations

Mutations

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

Mutations in Microorganisms

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

In silico analysis highlights the copy number variation mechanism responsible for the historically reported VWF exon 42 deletion.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Same author

Genetic analysis of bleeding disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Same author

Genomics of bleeding disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2014

Same author

Genetics of haemostasis.

Haemophilia : the official journal of the World Federation of Hemophilia·2012

Same author

Nomenclature of genetic variants in hemostasis.

Journal of thrombosis and haemostasis : JTH·2011

Same author

Another step towards understanding hemophilia A molecular pathogenesis.

Journal of thrombosis and haemostasis : JTH·2010

Search research articles

Related Experiment Video

Updated: Apr 15, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

Hemophilia B: molecular pathogenesis and mutation analysis.

¹Haemostasis Research Group, Department of Cardiovascular Science, Sheffield Children's NHS Foundation Trust, University of Sheffield and Sheffield Diagnostic Genetics Service, Sheffield, UK.

Journal of Thrombosis and Haemostasis : JTH

|April 9, 2015

Summary

Genetic analysis identifies over 97% of mutations causing hemophilia B, an inherited bleeding disorder. This aids in predicting inhibitor development and understanding disease mechanisms for better patient care.

Keywords:

DNA Mutational Analysis factor IX genetic carrier detection hemophilia B prenatal diagnosis

More Related Videos

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Related Experiment Videos

Last Updated: Apr 15, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Area of Science:

Genetics
Hematology
Molecular Biology

Background:

Hemophilia B is an X-linked inherited bleeding disorder primarily affecting males, with carrier females sometimes experiencing bleeding due to reduced Factor IX activity (FIX:C).
Genetic analysis has been crucial since the mid-1980s for tracking hemophilia B inheritance and identifying familial mutations.

Purpose of the Study:

To review the current landscape of genetic analysis in hemophilia B.
To discuss mutation detection rates, prediction of inhibitor development, and various underlying genetic mechanisms.
To highlight the role of large genetic databases and predictive algorithms in variant pathogenicity assessment.

Main Methods:

Linkage analysis for tracking inheritance.
Polymerase Chain Reaction (PCR) and Sanger sequencing for mutation detection.
Dosage analysis for identifying large deletions/duplications.

Main Results:

Mutation detection rates exceed 97% for hemophilia B patients using current genetic methods.
Inhibitor antibody development risk, associated with specific mutations (e.g., large deletions, nonsense mutations), can be predicted.
Analysis of genetic databases and algorithms aids in establishing variant pathogenicity.

Conclusions:

Genetic analysis is highly effective in diagnosing hemophilia B and understanding its genetic basis.
Predictive insights into inhibitor development improve patient management and risk assessment.
Ongoing research utilizing large databases and computational tools refines the understanding of variant pathogenicity in hemophilia B.